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Introduction
Patients with chronic headache who consume large
amounts of analgesics are often encountered in clinical
practice. Excessive intake of analgesics is now considered
to be a cause, rather than simply a consequence of frequent
headaches, and as such the diagnosis “medication overuse
headache” has been formulated[1]. Despite the prevalence
and clinical impact of medication overuse headache the
pathophysiology behind this disorder remains unclear and
specific mechanism-based treatment options are lacking.
Methods
Preclinical and clinical data from the literature were
reviewed.
Results and discussion
Although most acute headache treatments have been
alleged to cause medication overuse headache, here we
conclude that opioids are the drug class most strongly asso-
ciated with worsening headache. Recent evidence indicates
that chronic opioid administration may exacerbate pain in
the long-term by non-specifically activating Toll-Like
Receptor-4 on glial cells, resulting in a pro-inflammatory
state that manifests clinically as hyperalgesia[2]. We
hypothesise that medication overuse headache is a specific
form of opioid-induced hyperalgesia, which derives from a
cumulative interaction between central sensitisation, due to
repeated activation of nociceptive pathways by recurrent
headaches, and pain facilitation due to glial activation.
Conclusions
Treatment strategies directed at inhibiting glial activa-
tion may be of benefit in the management of medication
overuse headache. Potential treatment options could
include agents such as ibudilast, minocycline and
(+)-naltrexone.
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